ArticlePDF Available

Genetic Basis of Male Pattern Baldness

Authors:
Genetic Basis of Male Pattern Baldness
To the Editor:
Common pattern baldness (androgenetic alopecia) is the most
common form of hair loss in humans. In Caucasians, normal
male hair loss, commonly known as ‘‘male pattern baldness’
(MPB; MIM 109200), is noticeable in about 20% of men aged
20, and increases steadily with age, so that a male in his 90s has
a 90% chance of having some degree of MPB. In addition to
being among the most common natural conditions that make
men self-conscious, recent studies indicate associations of MPB
with: (1) benign prostatic hyperplasia (MIM 600082; odds ratio
(OR) ¼3.23; 95% con¢dence interval (CI): 1.81^5.79) (Hawk
et al, 2000); (2) coronary heart disease (relative risk ¼1.36; 95%
CI: 1.11^1.67) (Lotufo et al, 2000); (3) hyperinsulinemia
(OR ¼1.91; 95% CI: 1.02^3.56); and (4) insulin-resistance-asso-
ciated disorders, such as obesity (MIM 601665; OR ¼2.90; 95%
CI: 1.76^4.79), hypertension (MIM 145500; OR ¼2.09; 95% CI:
1.14^3.82), and dyslipidemia (OR ¼4.45; 95% CI: 1.74^11.34)
(Matilainen et al, 2000). MBP is also a risk factor for clinical pros-
tate cancer (MIM 176807; relative risk ¼1.50; 95% CI: 1.12^2.00)
(Oh et al, 1998). Although it is a widely accepted opinion that
common baldness is an autosomal dominant phenotype in men
and an autosomal recessive phenotype in women, or indeed that
baldness is genetically in£uenced, it is based on surprisingly little
empirical data. Here we grade MBP, in 476 monozygotic (MZ)
and 408 dizygotic (DZ) male twin pairs aged between 25 and 36
y and ¢nd a heritability of 0.81 (95% CI: 0.77^0.85), thus con-
¢rming that genetic e¡ects play a major part in the progression
of common hair loss.
Measures of hair loss were obtained in the course of an exten-
sive semistructured telephone interview with respondent book-
let, designed to assess physical, psychologic, and social
manifestations of alcoholism and related disorders, conducted
with 6265 twins born 1964 to 1971 from the volunteer-based Aus-
tralian Twin Registry. All males (45% of the sample) were asked
to rate their degree of hair loss, if any, using the Hamilton^Nor-
wood Baldness scale (Norwood, 1975) (a standard classi¢cation
scheme shown to have good test^retest reliability) (Hamilton,
1951; Norwood, 1975), which was printed i n the respondent book-
let (Fig 1). This data collection scheme was validated i n a study by
Ellis et al (1998), which compared participant self-assessment hair
loss against that determined by an independent trained observer
in their research clinic. Speci¢cally, the self-assessed rating of
score I in nine subjects was concurred by the trained observer in
all but one individual who received a score of II (p ¼0.317, Wil-
coxon matched pairs signed rank test), whereas no discrepancies
with observer’s scores were detected in ¢ve individuals with self-
assessed scores ranging from III to VII (Ellis et al,1998).
Data collected from 476 MZ and 408 DZ male pairs, plus 143
MZ and 154 DZ male individual twins (mean ages for the MZ
and DZ twins were 30.3 and 30.5 y, respectively) were analyzed
using structural equation modeling, to estimate parameters of a
model that include additive genetic e¡ects (A), nonadditive ge-
netic e¡ects (i.e., dominance or epistasis) (D), shared or family
environment (C), and random or unique environment (E) (Neale
and Cardon, 1992). In addition to the 12 Hamilton^Norwood ca-
tegories, scoring individuals who answered ‘no’’ to the question
‘have you experienced hair loss?’, as zero, resulted in a 13 -point
scale.
A major goal of the genetic analysis was to test the multiple
threshold model (Reich et al, 1972; Kendler, 1993), which posits
that di¡erent types of hair loss re£ect di¡erent levels of severity
on a single dimension, rather than distinct etiologies. These
thresholds can be regarded as the z-value of the normal distribu-
tion that divides the area under the curve in such a way that it
gives the right proportion of individuals in each (hair loss) group,
thus re£ecting the prevalence of each group (Neale and Cardon,
1992). For each of the two zygosity groups, the ¢t of a mul-
tiple threshold model was tested by calculating the poly-
choric correlation for the Hamilton^Norwood hair loss gradings,
using POLYCORR (http://ourworld.compuserve.com/homepages/
jsuebersax/xpc.htm) or PRELIS 2.30 ( J˛reskog and S˛rbom,
1999). The polychoric correlation, also termed the ‘‘correlation of
liability’, assumes that underlying the observed polychotomous
distribution of hair loss status there exists a continuous, normally
distributed latent liability (Kendler, 1993). A w
2
goodness-of-¢t
test is used to test whether the multiple threshold model provides
a good ¢t to the observed data. Calculation of 95% CI for the
polychoric correlations, the comparison of threshold values with-
in twin pairs and across zygosity groups, and genetic model
¢tting by maximum likelihood univariate analysis of raw data
were performed using the Mx program (Neale et al,1999).
Multiple threshold model tests performed on the 13 categories,
assuming equal thresholds for twin 1 and twin 2, indicated no
signi¢cant departure from normality in either MZ (w
2
155
¼117.94,
p¼0.99) or DZ twins (w
2
155
¼118.47, p ¼0.99), supporting a single
liability dimension model of hair loss. As contingency tables
using all 13 categories may be too sparse to yield a meaningful
test of the multiple threshold model, however (e.g., the w
2
statis-
tic may not be asymptotically distributed), the MZ and DZ data
were combined and the 13 score categories were collapsed into
the following eight groups: group 1 (0, I, II, IIa; representing
nonbaldness); group 2 (III); group 3 (IIIa); group 4 (IIIv, IV);
group 5 (IVa); group 6 (V); group 7 (Va), and group 8 (VI, VII).
Groups 2 to 8 represent signi¢cant cosmetic hair loss (Norwood,
1975), while maximizing counts for vertex and recessive hair loss.
Multiple threshold model tests performed on both the full 8 8
table and after combining frequencies in the two -diagonal quad-
rants, also indicated no signi¢cant departure from normality
(w
2
48
¼55.47, p ¼0.21 and w
2
18
¼19.5 8, p ¼0.36, respectively). These re-
sults strongly support a single liability dimension model of hair loss,
with frontal recession not etiologically distinct from vertex balding.
Subsequently, a single liability dimension-threshold model was
applied to our hair loss data, using the full distribution of ordered
hair loss scores (0^I^II^IIa^III^IIIa^IIIv^IV^IVa^V^Va^VI^VII)
as an ordered sequence re£ecting the severity of hair loss (see
Address correspondence and reprint requests to: Dr Dale R. Nyholt,
Queensland Institute of Medical Research, Post O⁄ce Royal Brisbane
Hospital, Brisbane QLD 4029, Australia. Email: daleN@qimr.edu.au
Electronic Database Information: accession number and URL for data in
this article are as follows: Online Mendelian Inheritance in Man (OMIM),
http://www.ncbi.nlm.nih.gov/Omim/(for MPB (MIM 109200), benign
prostatic hyperplasia (MIM 600082), obesity (MIM 601665), hypertension
(MIM 145500), and prostate cancer (MIM 176807)).
Manuscript received July 14, 2003; accepted for publication July 28, 2003
0022- 202X/03/$15.00 .Copyright r2003 by The Society for Investigative Dermatology, Inc.
1561
LETTER TO THE EDITOR
See related Commentary on pages v and vi
Fig 2). No signi¢cant di¡erences in threshold liability distribu-
tions were observed within twin pairs and across zygosity groups.
The age corrected maximum likelihood (ML) twin pair polycho-
ric correlation for hair loss gradings in MZ twin pairs (r¼0.81;
95% CI: 0.77^0.85) was over twice as large as the DZ correlation
(r ¼0.39; 95% CI: 0.28^0.49), indicating a strong genetic e¡ect.
Furthermore, genetic model ¢tting by ML univariate analysis of
raw data using Mx (Neale et al, 1999) (Ta b l e I ), indicated that an
additive genetic and nonshared environmental (AE) model best
explained individual di¡erences in MPB, and that 81% of the
total variance could be attributed to additive genetic e¡ects
(i.e., 81% heritability, 95% CI: 77^85%).
Given the di¡erences between some of the Hamilton^Nor-
wood gradings are quite subtle, we re-analyzed our data using
more clear-cut (dichotomous) categories of hair loss. For these
analyses, males with gradings of III, IIIa, IIIv, IV, IVa, V, Va, VI,
or VII were classi¢ed as bald, whereas males with gradings of 0,
I, II, or IIa were classi¢ed as nonbald. Analogous to the previous
genetic analyses, an AE model best explained individual di¡er-
ences in MPB, with 80% of the total variance attributed to addi-
tive genetic e¡ects (95% CI: 70^87%). Furthermore, the AE
model best explained individual di¡erences in MPB for dichoto-
mized clear-cut vertex balding (0, I, or II vs. IIIv, IV, V,VI, or VII)
and recessive balding (0, I, or II vs. IIIa, IVa, or Va) producing
heritability estimates of 89% (95% CI: 75^95%) and 96% (95%
CI: 87^99%), respectively. As predicted under the multiple
threshold model, and re£ected in their overlapping con¢dence in-
tervals, the use of di¡erent grouping thresholds/schemes does not
produce signi¢cantly di¡erent heritabilities.
Surprisingly, there is only one known extensive family study
on androgenetic alopecia published (Osborn, 1916). This study of
hair growth patterns in 22 families concluded that common bald-
ness is an autosomal dominant phenotype in men and an autoso-
mal recessive phenotype in women. Owing to a lack of details
regarding examination methods and the practice of omitting
symptom-free women in some pedigrees, however, the validity
of these results remain controversial. Additionally, although the
results from the two other known twin studies produced concor-
dance rates of 100% and 92.3% for MZ, and 50% and 68.7% for
DZ twins, they are far too smallincluding only three MZ and
Figure1. Hamilton^Norwood standards for classi¢cation of the most common types of MBP. Adapted from Norwood (1975). Types I, II, III, IV, V,
VI, and VII represent the most common forms of MPB. Type IIIv has no more front temporal hair loss than type III, but has considerable hair loss at the
vertex. Type A variants (IIa, IIIa, Iva, and Va) have hair loss restricted to the anterior region, which eventually recedes to equivalence with type VI (Nor-
wood, 1975). Frequencies in our sample (2029 males aged 25^36 y) are: zero hair loss (61.2%), I (6.5%), II (14.2%), IIa (2.9%), III (4.3%), IIIa (1.5%), IIIv
(3.8%), IV (1.6%), IVa (1.0%), V (0.8%), Va (1.1%), VI (0.4%), and VII (0.5%).
Figure 2. The multiple threshold model for the level of severity of
hair loss for the best ¢tting AE model.
1562 LETTER TO THE EDITOR THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
eight DZ male pairs (Niermann, 1964; Kuster and Happle, 1984),
and 65 MZ (42 male, 23 female) and 16 DZ (14 male, two female)
pairs (Hayakawa et al, 1992), respectivelyto permit reliable
conclusions.
Therefore, our results represent one of the ¢rst large-scale stu-
dies on the heritability of MBP and indicate that additive genetic
e¡ects play a major part in the progression of common hair loss.
Moreover, a recent study by Ellis et al (2001), which tested poly-
morphisms in the androgen receptor (AR)gene,foundaStuIre-
striction site in 98.1% of 54 young (18^30 y) bald men (p ¼
0.0005) and in 92.3% of 392 older (450 y) bald men
(p ¼0.000004) compared with 76.6% of 107 nonbald (450 y)
men, suggesting that a polymorphism in or near AR (and in link-
age disequilibrium with the AR StuI restriction site) is a contri-
buting, but not su⁄cient, component of the genetic pre-
disposition to MPB. Moreover, the AR gene is on chromosome
Xq11.2^q12 and therefore could not explain the similar hair loss
patterns shared between father and sons, as observed in an earlier
study on the same population, where 32 of 54 bald cases (59.3%)
had fathers with a greater degree of baldness, and only one of 65
sons of 50 nonbald controls had type III baldness or greater (Ellis
et al,1998).
Hair loss similarities between father and son have also been
observed in a study on the frequency of MPB in brothers of
men having prematurely bald fathers (66%) compared with
brothers of men with una¡ected fathers (46%; Harris, 1946; Kus-
ter and Happle, 1984). Further evidence against a single and/or
X-linked gene of major e¡ect comes from a study by Smith and
Wells (1964), which observed hair loss in only 33% of the fathers
of 18 women su¡ering from severe pattern baldness (Kuster and
Happle, 1984). Additionally, a study examining 410 men with
premature baldness found evidence of a genetic in£uence from
the fathers side in 236 cases (Galewsky, 1932; Jackson, 1932; Kuster
and Happle, 1984). Hence, other (autosomal) genes, possibly of
large e¡ect, remain to be found.
It is worth noting that these heritabilities are based on a
relatively young populationranging in age from 25 to 36 with
a mean of 30 y. As some of the nonbald subjects will inevitably
develop baldingwith the rate of baldness known to increase
steadily with ageit is possible that heritability (A) will di¡er
with age. For example, through the age-dependent expression of
genes, and/or a change in the body’s resilience to the major e¡ects
of a genetic in£uence in early phases of life. Also, the accumula-
tion of environmental in£uences (E) may play a larger part in
older ages. Twin studies in older cohorts are required to investi-
gate these possibilities.
The negative psychosocial e¡ects associated with male hair loss
include decreased self-esteem, dissatisfaction with body image or
appearance, self-consciousness, perception of aging, and often
emotional stress. Furthermore, these e¡ects tend to be more
pronounced in younger men (Girman et al, 1998). Certainly,
MPB in itself has a considerable e¡ect on the quality of life for
many men. Because it is a clearly observable trait, however,
which generally precedes the diagnosis of benign prostatic hyper-
plasia and clinical prostate cancer by decades (Hawk et al,2000),
genes in£uencing MPB may prove valuable in determining sus-
ceptibility to life-threatening prostatic disorders. Moreover, genes
in£uencing MPB, may lead to the identi¢cation of novel me-
chanisms, which may in£uence cardiovascular disease and/or in-
sulin resistance.
The authors wish to thank Dr David L Du¡y for many helpful discussions. This
re s ea rc h was sup p or t ed in pa r t b y gr ant s fro m N IA A A ( US A) no. AA0 7535, an d
NHMRC (Australia) no. 941177 and no. 951023. DRN was supported in part by
an NHMRC Peter Doherty Fellowship and NHMRC grant no. 241916.
Dale R. Nyholt, Nathan A. Gillespie, Andrew C. Heath,
and
Nicholas G. Martin
Genetic Epidemiology Laboratory, Queensland Institute of Medical
Research, Brisbane, Queensland, Australia;
Department of
Psychiatry, Washington University School of Medicine, St Louis,
Missouri, USA
REFERENCES
Ellis JA, Stebbing M, Harrap SB: Genetic analysis of male pattern baldness and the
5alpha-reductase genes. J Invest Dermatol 110:849^853, 1998
Ellis JA, Stebbing M, Harrap SB: Polymorphism of the androgen receptor gene is
associated with male pattern baldness. J Invest Dermatol 116:452^455, 2001
Galewsky E: Erkrankungen der Haare und des Haarbodens. In: Jadassohn J (ed.)
Handbuch der Haut- und Geschtskrankheiten, Vol. 13/1. Berlin: Springer-Verlag,
1932; p 216^220
Girman CJ, Rhodes T, Lilly FRW, Guo SS, Siervogel RM, Patrick DL, Chumlea
WC: E¡ects of self-perceived hair loss in a community sample of men. Derma-
tology 197:223^229, 1998
Hamilton JB: Patterned loss of hair in man: Types and incidence. Ann NY Acad Sci
53:708^728, 1951
Harris H: The inheritance of premature baldness in men. Ann Eugenics 13:172^181,
19 4 6
Hawk E, Breslow RA, Graubard BI: Male pattern baldness and clinical prostate can-
cer in the epidemiologic follow-up of the ¢rst National Health and Nutrition
Examination Survey. Cancer Epidemiol Biomarkers Prev 9:523^527, 2000
Hayakawa K, Shimizu T, Ohba Y, et al: Intrapair di¡erences of physical aging and
longevity in identical twins. Acta Genet Med Gemellol (Roma) 41:177^185, 1992
Jackson: Diseases of the hair and scalp. New York: 1890 (Cited according to Galewsky E,
193 2 )
J˛reskog KG, S˛rbom D: PRELIS: 2.30 for Windows. Chicago: Scienti¢c Software
International Inc., 1999
Kendler K: Twin studies of psychiatric illness: Current status and future directions.
Arch Gen Psychiatry 50:905^915, 1993
Kuster W, Happle R: The inheritance of common baldnes: Two B or not two B?
JAmAcad Dermatol11:921^926, 1984
Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE: Male pattern baldness
and coronary heart disease: The Physicians Health Study. Arch Intern Med
160:165^171, 2000
Matilainen V, Koskela P, Keinanen-Kiukaanniemi S: Early androgenetic alopecia as a
marker of insulin resistance. Lancet 356:1165^1166, 2000
Table I. Genetic model ¢tting results using m aximum likelihood raw data methods
Goodness of ¢t
Model A C D E 2LL d.f. D-2LL Ddf p vs. Model
ADE 0.75 0.06 0.19 5485.58 2013
ACE 0.81 0.0 0 0.19 5 4 85.6 8 2013
AE
a
0.81 0.19 5 485.68 2 014 0.09 1 0.76 ADE
CE 0.62 0.38 5552.84 2014 67.16 1 o0.001 ACE
Liability thresholds, computed using PRELIS 2.30 ( J˛reskog and S˛rbom, 1999), were utilized as starti ng values for the maximum likelihood univariate genetic ana-
lysis of raw data, performed using the Mx program (Neale et al, 1999). The correlation between age and baldness was accounted for by simultaneously estimating and
applying a single age displacement (normalized regression coe⁄cient) (b¼^0.06) to the threshold distribution. First, a fully ‘‘saturated’’ model (ADE or ACE) was tested
to evaluate the statistical properties of the data, then the e¡ect of dropping one of the parameters (A, C, D, or E) was examined by testing the respective di¡erence (D-
2LL) for statistical signi¢cance.
a
The AE model was found to provide the most parsimonious ¢t to the data.
LETTER TO THE EDITOR 1563VOL. 121, NO. 6 DECEMBER 2003
Neale MC, Cardon LR: Methodology for Genetic Studies inTwins and Families.NATO
ASI Serie s. Dordrecht: K luwer Academic Publishers, 1992
Neale MC, Boker SM, Xie G, Maes HH: Mx: Statistical Modeling, 5th edn. Box 126
MCV, Richmond,VA 23298. Department of Psychiatry, 1999
Niermann H: Zwillingsdermatolgie. Berlin: Springer-Verlag, 1964
Norwood OT: Male pattern baldness: Classi¢cation and incidence. South Med J
68:1359^1365, 1975
Oh BR, Kim SJ, Moon JD, et al: Association of benign prostatic hyperplasia with
male pattern baldness. Urolo gy 51: 74 4^ 748, 19 98
Osborn D: Inheritance of baldness. JHered7:347^355, 1916
ReichT, James J, Morris C:The use of multiple thresholds in determini ng the mode
of transmission of semi-continuous traits. Ann Hum Genet 36:163^184, 1972
Smith MA, Wells RS: Male-type alopecia, alopecia areata, and normal hair in
women. Arch Dermatol 89:155^158, 1964
156 4 LETTER TO THE EDITOR THE JOURNAL OF INVESTIGATIVE DERM ATOLOGY
... Usually, women lose hair in diffuse patterns over the top of the scalp, while men present a hairline/ balding delineation at the temples and vertex. Even so, multiple and relatively common (genetic, environmental, etc.) factors are involved, in both men and women (2). The most common treatment methods are represented by finasteride and minoxidil administration, with some studies also suggesting tretinoin, ketoconazole and spironolactone (3,4). ...
... As a consequence, the serum level of dihydrotestosterone decreases after Finasteride administration with about 65-70%. The partial inhibition of dihydrotestosterone synthesis is due to the fact that Finasteride doesn't inhibit the type I of 5 alphareductase isoenzyme (1,2). ...
... Variants in AR influence androgen sensitivity, while other genes are involved in various aspects of HF biology, including cell cycle regulation, extracellular matrix remodeling, and lipid metabolism. While there is some debate, experts put the genetic contribution to AGA at 80%, with the remaining 20% of input coming from environmental influences [30]. ...
Article
Introduction: Androgenetic alopecia (AGA) is the most common cause of hair loss worldwide. The significant psychological and social impact of AGA continues to drive demand for more effective treatments beyond the limited options currently available. Areas covered: The authors review the key components of AGA pathogenesis, as well as current treatments, and therapeutic techniques under development. Innovative strategies for AGA drug discovery are still needed, given the significant unmet medical needs and the limited efficacy of both current and emerging treatments. The authors outline relevant preclinical models, such as hair follicle (HF) cell cultures, 3D spheroids, organoids, follicle explants, and animal models, highlighting their advantages and limitations in AGA research. Finally, they summarize the primary objectives in AGA treatment development, including direct hair growth promotion, interference with androgen signaling, and HF rejuvenation, identifying key pathogenesis intervention points for treatment development. Expert opinion: Developing better in vitro models, possibly using induced pluripotent stem cell (iPSC) systems, could greatly accelerate drug discovery. Similarly, a superior in vivo model could significantly expedite drug discovery. Near future development research should focus on drug delivery improvements. Longer term, treatments targeting AGA’s underlying pathophysiology and promoting HF rejuvenation or true regeneration would provide the most benefit to prospective patients.
... Early studies on twins attributed ≈80% of the phenotypical variance of AGA to additive genetic factors [4]. Accordingly, genome-wide association studies (GWASs) conducted over the subsequent two decades identified more than 350 risk genomic regions and more than 600 independent, common, single nucleotide polymorphisms (SNPs) [5]. ...
Article
Full-text available
Single nucleotide polymorphisms (SNPs) found to be associated with Androgenetic Alopecia (AGA) to date, are characterized by an apparent reduced penetrance into the phenotype suggesting a role of other factors in the etiology of AGA. Objective: We conducted a study to investigate the role of specific allelic variants in AGA controlling for nutritional and lifestyle factors. Methods: Individual patterns of SNPs present in the baldness susceptibility locus at 20p11 (rs1160312 and rs6113491) or close to the androgen receptor (AR) gene in chromosome X (rs1041668) were investigated in 212 male subjects. Information on socio-demographic characteristics, medical history, smoking, and diet was also collected. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results: After controlling for age, diet, BMI, family history of AGA, and smoking, an increased risk of AGA was found for subjects with [A] alleles for both rs1160312 (OR: 2.97; 95% CI: 1.34–6.62) and rs6113491 (OR: 2.99; 95% CI: 1.37–6.52), and for subjects with the TT genotype for rs1041668 (OR: 4.47; 95% CI: 1.60–12.5). Multivariate logistic regression indicates that diet, familiarity, and BMI, but not smoking, remain statistically significant despite the different SNP genotypes. Conclusions: To our knowledge, this is the first indication that the rs1160312, rs6113491, and rs1041668 polymorphisms are independent risk factors for AGA that can be modulated by diet.
... Наследуемость АГА составляет более 80% [26]. В ходе молекулярно-генетических исследований определено более 200 областей в геноме, связанных с предрасположенностью к АГА. ...
Article
Androgenetic alopecia is a multifactorial pathological condition formed as a result of the genetic sensitivity of hair follicles to androgens, characterized by miniaturization of hair and their progressive loss. The extremely widespread prevalence of pathology, its serious negative impact on the mental and emotional state of patients, including a decrease in self-esteem, dissatisfaction with their appearance and perception of aging, as well as the occurrence of chronic emotional stress significantly reduces the quality of life for both women and men, especially at a young age, which is an important medical and social problem. The difficulty and duration of treatment dictate the need for further research and implementation of new approaches to the correction of this disease in practical healthcare. The article provides a review of literature sources, both Russian and foreign authors, devoted to this problem, highlights various environmental factors such as exposure to ultraviolet rays, decreased sleep duration, increased chronic stress, high body mass index, circulatory disorders due to smoking, hypertension, hyperinsulinemia, oxidative stress, etc. The article highlights the important links of pathogenesis in the occurrence of androgenetic alopecia, which opens up the main points of application of therapy at the level of hair follicles: reducing the intracranial conversion of testosterone to dihydrotestosterone by inhibiting 5α-reductase, improving blood supply to the follicle and stimulating its growth with signaling peptides. New methods of treatment of androgenetic alopecia aimed at one or more points of the pathogenesis of androgenetic alopecia are described: topical therapy, systemic drugs, injectable methods of delivering proteins – intrinsic growth factors into the scalp (plasma therapy – the introduction of autologous plasma rich in platelets), physiotherapy using various physical methods of exposure, as well as surgical transplantation hair. Thus, the literature review, which is offered to medical specialists interested in trichological problems, presents the results of the clinical effectiveness of using various techniques in the complex therapy of androgenetic alopecia.
... Most participants experienced onset between ages 26-35 (58%), with an average onset age of 29.9 years. Comparable studies reported an average onset of 30.6 years among males with baldness, [10] and other report noted an onset average of 22.8 years [11]. A majority (70%) of our patients had a positive family history of AGA, which correlated with findings from other studies [12][13]. ...
Article
Background: Androgenetic alopecia (AGA) is a common form of hair loss affecting both men and women, characterized by progressive thinning of hair, particularly in the scalp's vertex and frontal areas. Treatments such as minoxidil and platelet-rich plasma (PRP) have been developed to manage AGA, each with distinct mechanisms and efficacy profiles. Objective: This study aimed to compare the efficacy of Minoxidil, Dermaroller, and PRP in treating AGA, evaluating their impact on hair growth and patient satisfaction. Methodology: This prospective comparative parallel-group interventional study was conducted on the outpatient department of Dermatology, tertiary hospital, between December 2022 and May 2023. Where male participants aged 18-45 years with grade II, III, or IV AGA were enrolled. Ninety patients were randomly assigned to three groups: Group A received 5% minoxidil twice daily; Group B received the same minoxidil regimen with monthly dermaroller treatment; Group C received 5% minoxidil along with monthly PRP injections. Participants were assessed at baseline, 3 months, and 5 months using photographic documentation and dermoscopy to measure hair growth improvements. Results: The mean age of participants was 29.90 ± 5.50 years, with a balanced gender distribution (1:1 male to female ratio) and a significant family history of AGA (70%). PRP with minoxidil demonstrated superior efficacy compared to minoxidil alone or minoxidil with dermaroller, showing significant improvements in hair counts at both 3 months (p=0.01) and 5 months (p<0.001). Dermaroller with minoxidil also showed improvements, though not statistically significant compared to minoxidil alone. Secondary efficacy analysis revealed significant shifts towards hair growth enhancement in the PRP + minoxidil group. Conclusion: PRP combined with minoxidil represents a promising and effective treatment option for AGA, offering superior outcomes compared to minoxidil alone or minoxidil with dermaroller. This combination therapy enhances hair growth through its regenerative effects on hair follicles, making it a valuable option for patients seeking non-surgical interventions with high satisfaction rates.
... In our study, there was a high statistically significant relationship between family history of AGA and TE/AGA than TE/AGA/TA than other groups (P<0.001). This agrees with Nyholt et al, 25 who reported that genetic factors have a main role in etiopathogenesis of FAGA. Our current study might agree with the result of a retrospective study by Siah et al, 26 who found that nearly 85 percent of FAGA patients had a family history of AGA. ...
... Genetic predisposition and hormonal changes are involved in SA pathogenesis [14]. Studies on monozygotic and dizygotic twins have shown that genetic factors are strong [15], while studies on monozygotic twins have shown that internal and external factors affect alopecia [16], suggesting the involvement of factors other than heredity. Environmental factors affecting the scalp include sebum and microorganisms. ...
Article
Full-text available
The current status of seborrheic alopecia (SA) in young people and its potential association with fungal infections was discussed. Pathological representations, pathogenesis and therapeutic strategies of seborrheic alopecia were introduced. SA is the most common type of hair loss in adults, but it also occurs in adolescents, though its prevalence among this younger population is not well established. Skin biocenosis, in particular the Malassezia spp. flora, plays a key aetiologic role, in combination with the unusual capacity of some corneocytes to be coated by these yeasts.
Article
Full-text available
Androgenetic alopecia (AGA), a leading cause of progressive hair loss, affects up to 50% of males aged 50 years, causing significant psychological burden. Current treatments, such as anti-androgen drugs and minoxidil, show heterogeneous effects, even with long-term application. Meanwhile, the large-scale adoption of other adjuvant therapies has been slow, partly due to insufficient mechanistic evidence. A major barrier to developing better treatment for AGA is the incomplete understanding of its pathogenesis. The predominant academic consensus is that AGA is caused by abnormal expression of androgens and their receptors in individuals with a genetic predisposition. Emerging evidence suggests the contributing role of factors such as immune responses, oxidative stress, and microbiome changes, which were not previously given due consideration. Immune-mediated inflammation and oxidative stress disrupt hair follicles’ function and damage the perifollicular niche, while scalp dysbiosis influences local metabolism and destabilizes the local microenvironment. These interconnected mechanisms collectively contribute to AGA pathogenesis. These additional aspects enhance our current understanding and confound the conventional paradigm, bridging the gap in developing holistic solutions for AGA. In this review, we gather existing evidence to discuss various etiopathogenetic factors involved in AGA and their possible interconnections, aiming to lay the groundwork for the future identification of therapeutic targets and drug development. Additionally, we summarize the advantages and disadvantages of AGA research models, ranging from cells and tissues to animals, to provide a solid basis for more effective mechanistic studies.
Article
Male androgenetic alopecia (MAA) is quite common and worsens with age, with a significant impact on quality of life, and is increasingly a reason for consultation with a dermatologist. The etiopathogenesis of MAA is multifactorial and genetic and hormonal influences stand out. MAA starts with the process of follicular miniaturization in diverse phenotypic patterns. The diagnosis of MAA is basically clinical and currently corroborated by well-established trichoscopic findings. Despite this, therapeutic options are limited, especially when one considers medications with a high level of scientific evidence. This review aims to help the general dermatologist towards a better understanding of MAA providing a basis for good individualized and judicious therapeutic decisions.
Article
Background: Pilonidal sinus disease is a highly morbid condition characterized by the formation of chronic sinus tracts throughout the sacrococcygeal region. Despite its commonality and strong association with family history, there is no prior investigation of genetic risk factors for pilonidal sinus disease. Objective: To identify genetic risk factors for pilonidal sinus disease. Design: Genome-wide association study. Settings: The United Kingdom Biobank, FinnGen Biobank, and PennMedicine Biobank. Patients: There were 772,072 participants. Main outcome measure: Genome-wide significant variants (p < 5x10 -8) were mapped to genes using physical distance and gene expression in skin. Genetic correlation between pilonidal sinus disease and morphometric, androgen-driven, and hair phenotypes was estimated with LD score regression. Finally, a genome-first approach to rare, predicted deleterious variants in hair shaft genes TCHH, PADI3, and TGM3 was conducted for association with pilonidal sinus disease via PennMedicine Biobank. Results: Genome-wide association study comprised of 2,835 individuals with pilonidal sinus disease identified 5 genome-wide significant loci, prioritizing HDAC9, TBX15, WARS2, RP11-293M10.1, PRKAR1B, TWIST1, GPATCH2L, NEK9, and EIF2B2, as putative causal genes; several of these genes have known roles in balding and hair patterning. There was significant correlation between the genetic background of pilonidal sinus disease and that of the androgen-driven hair traits male pattern baldness and young age at first facial hair. In a candidate analysis of genes associated with syndromic hair disorders, rare coding variants in TCHH, a monogenic cause of uncombable hair syndrome, were associated with increased prevalence of pilonidal sinus disease (OR 4.81 [5% CI, 2.06-11.2]). Limitations: This study is limited to European ancestry. However, because there is a higher incidence of pilonidal sinus disease in men of European ancestry, this analysis is focused on the at-risk population. Conclusion: Genetic analysis of pilonidal sinus disease identified shared genetic architecture with hair biology and androgen-driven traits. As the first study investigating the genetic basis of pilonidal sinus disease, this provides biological insight into the long-appreciated connection between the disease state, male gender, and hair. See Video abstract.
Book
Preface. List of Figures. List of Tables. 1. The Scope of Genetic Analyses. 2. Data Summary. 3. Biometrical Genetics. 4. Matrix Algebra. 5. Path Analysis and Structural Equations. 6. LISREL Models and Methods. 7. Model Fitting Functions and Optimization. 8. Univariate Analysis. 9. Power and Sample Size. 10. Social Interaction. 11. Sex Limitation and GE Interaction. 12. Multivariate Analysis. 13. Direction of Causation. 14. Repeated Measures. 15. Longitudinal Mean Trends. 16. Observer Ratings. 17. Assortment and Cultural Transmission. 18. Future Directions. Appendices: A. List of Participants. B. The Greek Alphabet. C. LISREL Scripts for Univariate Models. D. LISREL Script for Power Calculation. E. LISREL Scripts for Multivariate Models. F. LISREL Script for Sibling Interaction Model. G. LISREL Scripts for Sex and GE Interaction. H. LISREL Script for Rater Bias Model. I. LISREL Scripts for Direction of Causation. J. LISREL Script and Data for Simplex Model. K. LISREL Scripts for Assortment Models. Bibliography. Index.
Article
The articles published by the Annals of Eugenics (1925–1954) have been made available online as an historical archive intended for scholarly use. The work of eugenicists was often pervaded by prejudice against racial, ethnic and disabled groups. The online publication of this material for scholarly research purposes is not an endorsement of those views nor a promotion of eugenics in any way.
Article
The need for a widely accepted, accurate, and reproducible standard of classification for male pattern baldness has increased with the advent and increasing popularity of hair transplant surgery. This report establishes such a classification, and reports its use in determining the incidence of male pattern baldness at various ages in 1,000 white adult male subjects. The action of testosterone as an incitant in male pattern baldness is well known, but this study points out the continued effect of time, even in later years. Since most hair transplant surgery is peformed on subjects with male pattern baldness, and because the success of hair transplant surgery is largely dependent on proper patient selection, a complete understanding of male pattern baldness is essential for consistently good results with hair transplantation.
Article
The genetic and environmental contributions to physical aging (hair graying, balding, presbyopia) and longevity (age at death) were examined by within-pair comparison in monozygotic (MZ) and dizygotic (DZ) twins in later adulthood. Physical aging was investigated on 135 pairs of adult twins aged over 50. Hair graying and hair loss (baldness) showed significantly higher rates of concordance in the MZ twins than in the DZ twins. The intrapair difference of the degree of hair graying was negligible in 79%, slight in 15% and striking in 5% among the MZ pairs; while negligible in 40%, slight in 50% and striking in 10% among the DZ pairs. The intrapair difference of the degree of hair loss was negligible in 92%, slight in 8% (and striking in none) among the MZ pairs; while negligible in 69%, slight in 25% and striking in 6% among the DZ pairs. The age at onset of presbyopia showed a slightly higher rate of concordance in the MZ than in the DZ pairs. Longevity (age at death) was surveyed on 184 pairs of twins who died at over 40 years of age. The intrapair difference of longevity was 6.65 +/- 5.6 years (maximum 18.0; minimum 0.04) in the MZ pairs, and 8.66 +/- 7.2 years (maximum 18.6; minimum 2.9) in the DZ pairs. The MZ pairs showed a slightly smaller within-pair difference of longevity than the DZ pairs.
Article
So far, it is a widely accepted opinion that androgenetic alopecia is caused by an autosomal dominant gene with reduced penetrance in women. This view is essentially based on a family study performed by Osborn in 1916. She believed that balding men would be either heterozygous (Bb) or homozygous (BB), whereas balding women would be homozygous (BB). By contrast, we here present five arguments favoring a polygenic inheritance of the trait: (1) the high prevalence of the trait, (2) the distribution of balding patterns in the general population along a gaussian curve of variation, (3) the fact that the risk increases with the number of relatives already affected, (4) the slightly increased risk of relatives of severely affected women as compared to the relatives of mildly affected women, and (5) the fact that a predisposition inherited from an affected mother is of greater importance than that inherited from an affected father. In conclusion, the simple mendelian model of Bb and BB can no longer be upheld.
Article
ALTHOUGHTWIN TWIN studies have made a major contribution to the field of psychiatry over the last 65 years, recent developments have considerably expanded the range and sophistication of psychiatric twin research. Particularly important have been (1) the introduction of biometrical model fitting, (2) the use of population-based twin samples, and (3) the expansion of twin studies to include two or more disorders, specified environmental risk factors, multiple assessments or informants, nontwin relatives, and longitudinal observations. The equal environment assumption for psychiatric twin studies has been more rigorously examined and continues to receive empirical support. Twin studies are beginning to examine genotypeenvironment interaction in the etiology of psychopathologic conditions and to address the nature of putative environmental risk factors, such as stressful life events. Methods are being developed to incorporate specified genotypes, assessed using modem gene mapping techniques, into twin studies. With increasing conceptual rigor and methodologic sophistication, twin studies will
Article
Both benign prostatic hyperplasia (BPH) and male pattern baldness (androgenic alopecia) share the pathogenesis of an androgen-dependent disorder and afflict a large population of elderly men with chronobiologic progress. However, it is unclear whether these diseases are related epidemiologically. We evaluated the association of frequency and severity of male pattern baldness between patients with BPH and a control group. A total of 225 patients with BPH (mean age 69.3 +/- 6.5 years) and 1 60 controls (mean age 68.5 +/- 6.4 years), all over 60 years of age, were included in this study. The estimation of baldness severity was based on Norwood's classification (grade I to VII). The International Prostate Symptom Score (IPSS) and genetic tendency for baldness were also evaluated. The difference between IPSS and grade of baldness between the two groups was analyzed by the Mann-Whitney test and the frequency of inherited baldness was compared by the chi-square test. Correlation between severity of baldness and IPSS in each group was estimated by Spearman's rank correlation method. The patients with BPH had an apparently higher grade of male pattern baldness in comparison with that of controls (median value of grade IV versus III, P <0.001). The proportion of men with male pattern baldness of grade IV or higher in the BPH group was significantly larger than that of controls (53.8% versus 36.9%, P <0.01). There was a greater frequency of inherited baldness in the BPH group than in the controls (31.6% versus 12.5%, P <0.001). No significant correlation was noted between baldness severity and IPSS in either group. This study demonstrates a strong association of BPH with male pattern baldness.